Show simple item record

dc.contributor.author
Spitaleri, G.
dc.contributor.author
Berardi, R.
dc.contributor.author
Pierantoni, C.
dc.contributor.author
De Pas, T.
dc.contributor.author
Noberasco, C.
dc.contributor.author
Libbra, C.
dc.contributor.author
Gonzalez-Iglesias, R.
dc.contributor.author
Giovannoni, L.
dc.contributor.author
Tasciotti, A.
dc.contributor.author
Neri, Dario
dc.contributor.author
Menssen, H. D.
dc.contributor.author
Braud, F. de
dc.date.accessioned
2017-06-19T15:19:30Z
dc.date.available
2017-06-19T15:19:30Z
dc.date.issued
2013
dc.identifier.issn
0171-5216
dc.identifier.issn
1432-1335
dc.identifier.other
10.1007/s00432-012-1327-7
dc.identifier.uri
http://hdl.handle.net/20.500.11850/163433
dc.language.iso
en
dc.publisher
Springer
dc.subject
Armed antibody
dc.subject
Immunocytokine
dc.subject
L19-TNF
dc.subject
Phase I/II trial
dc.subject
Vascular targeting
dc.subject
Vasodisruptive therapy
dc.title
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours
dc.type
Journal Article
ethz.journal.title
Journal of cancer research and clinical oncology
ethz.journal.volume
139
ethz.journal.issue
3
ethz.journal.abbreviated
J. cancer res. clin. oncol.
ethz.pages.start
447
ethz.pages.end
455
ethz.notes
Received 14 September 2012, Accepted 24 September 2012, Published online 17 November 2012.
ethz.identifier.wos
ethz.identifier.nebis
000986054
ethz.publication.place
Berlin
ethz.publication.status
published
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario / Neri, Dario
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario / Neri, Dario
ethz.date.deposited
2017-06-19T15:20:35Z
ethz.source
ECIT
ethz.identifier.importid
imp59365064aa6e774045
ethz.ecitpid
pub:102093
ethz.eth
yes
ethz.availability
Metadata only
ethz.rosetta.installDate
2017-07-26T20:32:06Z
ethz.rosetta.lastUpdated
2019-02-02T10:35:10Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Phase%20I/II%20study%20of%20the%20tumour-targeting%20human%20monoclonal%20antibody-cytokine%20fusion%20protein%20L19-TNF%20in%20patients%20with%20advanced%20solid%20tumo&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.date=2013&rft.volume=139&rft.issue=3&rft.spage=447&rft.epage=455&rft.issn=0171-5216&1432-1335&rft.au=Spitaleri,%20G.&Berardi,%20R.&Pierantoni,%20C.&De%20Pas,%20T.&Noberasco,%20C.&rft.genre=article&
 Search via SFX

Files in this item

FilesSizeFormatOpen in viewer

There are no files associated with this item.

Publication type

Show simple item record